JPRN-UMIN000048684已完成未知
Validation research study on migraine (Validation research study using questionnaire surveys and health insurance association medical claim data) - Validation research study on migraine
Otsuka Pharmaceuticals Co., Ltd0 个研究点目标入组 21,480 人开始时间: 2022年9月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 21,480
研究概览
简要总结
sing a questionnaire linked claim data,we examined the most appropriate receipt conditions for migraine subjects identified by the ICHD-3 and 2 screeners.The most common combination of the PPV was "at least two migraine diagnoses and at least one prescription of migraine prophylaxis or triptans in the same month as the migraine diagnosis", suggesting that these were appropriate conditions for the migraine patients identified in the ICHD-3 condition
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 19years-old 至 74years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
尚未招募
不适用
Sequential, Multiple Assignment, Double Randomized Preference, Migraine Behavioral TrialHeadacheChronic MigraineHeadache DisordersMigraineNCT06170281Mayo Clinic24
招募中
不适用
Trial Designs for Evaluating Migraine TreatmentHeadache, MigraineMigraine With AuraMigraine Without AuraNCT06617832University of Aarhus128
招募中
不适用
Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic MigraineChronic MigraineEpisodic MigraineMigraineNCT06603558AbbVie3,000
Unknown
1 期
Status Migrainosus - Differentiating Between Responders and Non-respondersMigraineNCT03066544Hartford HealthCare50
已完成
不适用
STOPAIN in the Treatment of a Single Migraine AttackHeadacheMigraineNCT01687101Thomas Jefferson University32
